Sponsored by

Genentech Biooncology

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 2451 to 2475 of about 5861

Previous 25

Website Changes

06/22/2012

The effects of the NICE Technology Appraisal 121 (Gliadel and Temozolomide) on survival in high-grade glioma.

06/22/2012

Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma.

06/21/2012

06/14/2012

Fred Hutch Spinoff Blaze Bioscience Pulls in $5M For ‘Tumor Paint’

06/13/2012

Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma.

06/09/2012

Please be advised that the Brainstorm seminar: Coping with the Side Effects of Medications that was scheduled for Wednesday, June 13, 2012 at Monmouth Medical Center, Long Branch, NJ has been canceled.

06/05/2012

Sign-ups for Camp Jinka 2012 have begun!

06/03/2012

Noninvasive Application of Alternating Electric Fields in Glioblastoma : A Fourth Cancer Treatment Modality. Overview of how the deivce works!

06/03/2012

Noninvasive Application of Alternating Electric Fields in Glioblastoma : A Fourth Cancer Treatment Modality. Overview of how the Novocure TTF100-a Device works!

06/03/2012

Steroid-sparing effects of angiotensin-II inhibitors in glioblastoma patients.

06/03/2012

Musella Foundation Co-Pay Assistance program is now closed!

05/30/2012

Novocure to present NovoTTF Therapy Data at the 2012 Annual Scientific Meeting of the American Society Of Clinical Oncology!

05/28/2012

The trouble with brain scans

05/27/2012

Claudette Saville Felice on the Go Grey in May 5K

05/24/2012

Novocure(TM) Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy

05/23/2012

IBTA Newsletter

05/23/2012

Drug shrinks melanoma metastases in the brain

05/22/2012

Coping with Side Effects of Medications

05/21/2012

Study Results of Novocure’s Pivotal Phase 3 Trial Published in European Journal of Cancer Show that NovoTTF™ Therapy was Comparable to Physicians’ First Chemotherapy Choice in Clinical Efficacy with Better Quality of Life Outcomes in Patients with Recurrent Glioblastoma

05/21/2012

Further Progress Made For DCVax-L Brain Cancer Clinical Trial

05/21/2012

NovoTTF-100A versus physician`s choice chemotherapy in recurrent glioblastom: a randomized phase 3 trial of a novel treatment modality. This is the report on the large trial that let to the FDA approval of the Novocure device

05/21/2012

Young At Heart Productions Announces the Making of: Discovering The Beating Path

05/20/2012

Revised glioblastoma classification should improve patient care

05/18/2012

Northwest Bio Provides Update On DCVax®-L Brain Cancer Trial [Upgraded to phase 3!]

05/18/2012

Olanzapine May Manage Nausea and Vomiting From Chemotherapy When Other Treatments Fail

Our privacy / cookie policy has changed.
Click HERE to read it!